RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology
Author:
Publisher
Springer Singapore
Link
http://link.springer.com/content/pdf/10.1007/978-981-32-9755-5_1
Reference62 articles.
1. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT (2009) Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res 15:3654–3662
2. Aguilar-Mahecha A, Cantin C, O’Connor-McCourt M, Nantel A, Basik M (2009) Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker. Proteome Sci 7:15
3. Bailey CH, Jameson G, Sima C, Fleck S, White E, Von Hoff DD, Weiss GJ (2012) Progression-free survival decreases with each subsequent therapy in patients presenting for phase I clinical trials. J Cancer 3:7–13. PMID: 22211140
4. Baldelli E et al (2015a) Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors. Oncotarget 6(32):32368–32379
5. Baldelli E et al (2015b) Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: implications for personalized medicine. Proteomics Clin Appl 9(9–10):928–937
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models;Scientific Reports;2024-08-27
2. Plasma/Serum Proteomics based on Mass Spectrometry;Protein & Peptide Letters;2024-03
3. Diffusion-Enhanced Graph Attention Network for Cancer Type Classification;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05
4. Liquid Biopsies, Novel Approaches and Future Directions;Cancers;2023-03-03
5. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice;Proteomes;2023-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3